Position history for BlackRock, Inc.'s holdings in ARCUTIS BIOTHERAPEUTICS INC
BlackRock, Inc. holds 9.2M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $216.8M as of 2026-Q1. The position was increased (+1.1% shares). ARQT represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$216.8M
Current Shares
9.2M
Total Value Change
+$89.3M
Total Shares Change
+51,853
Other major holders of ARQT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 9.2M |
+1.1% |
| $216.8M |
| 0.0% |
| $23.60 |
31 |
| 2025-Q4 | Increased | 9.1M | +6.1% | $264.3M | 0.0% | $28.08 | 33 |
| 2025-Q3 | Increased | 8.6M | +0.5% | $161.6M | 0.0% | $18.62 | 30 |
| 2025-Q2 | Decreased | 8.5M | -4.0% | $119.6M | 0.0% | $13.74 | 0 |
| 2025-Q1 | Decreased | 8.9M | -2.8% | $139.1M | 0.0% | $15.73 | 0 |
| 2024-Q4 | New | 9.1M | - | $127.4M | 0.0% | $14.20 | 42 |